1 |
李丽,孟刚,汪小霞,等.乳腺浸润性小叶癌的临床病理特征[J].临床与实验病理学杂志,2015,31(4):390-394,399.
|
2 |
Biglia N, Mariani L, Sgro L, et al.Increased incidence of lobular breast cancer in women treated with hormone replacement therapy:implications for diagnosis, surgical and medical treatment[J].Endocr Relat Cancer, 2007, 14(3):549-567.
|
3 |
李洪林,姜玉新,郝玉芝,等.超声对乳腺恶性肿瘤疾病的诊断价值[J].中国医学影像技术,2006,22(6):870-872.
|
4 |
李崖青,郭晓静,刘芳芳,等.乳腺浸润性小叶癌的研究进展[J].中国肿瘤临床,2012,39(3):170-173.
|
5 |
焦良和,沈美萍.乳腺浸润性小叶癌患者阳性手术切缘的预测因素分析[J].中华全科医学,2018,16(9):1431-1434,1458.
|
6 |
陈谦谦,薛恩生.超声、钼靶X线联合MRI在乳腺癌术前评价中的应用[J].中国医学影像学杂志,2012,20(2):148-152.
|
7 |
Heil J, Buehler A, Golatta M, et al.Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI? [J].Ann Oncol, 2012, 23(1):98-104.
|
8 |
Mann RM, Loo CE, Wobbes T, et al.The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast[J].Breast Cancer Res Treat, 2010, 119(2):415-422.
|
9 |
Lee J, Tanaka E, Eby PR, et al.Preoperative breast MRI:surgeons′patient selection patterns and potential bias in outcomes analyses[J].AJR Am J Roentgenol, 2017, 208(4):923-932.
|
10 |
Debald M, Abramian A, Nemes L, et al.Who may benefit from preoperative breast MRI? A single-center analysis of 1102 consecutive patients with primary breast cancer[J].Breast Cancer Res Treat, 2015, 153(3):531-537.
|
11 |
中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2017年版)[J].中国癌症杂志,2017,27(9):695-759.
|
12 |
Houssami N, Turner R, Morrow M.Preoperative magnetic resonance imaging in breast cancer:meta-analysis of surgical outcomes[J].Ann Surg, 2013, 257(2):249-255.
|
13 |
Hwang N, Schiller DE, Crystal P, et al.Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma:its effect on ipsilateral breast tumor recurrence after breast-conservation therapy[J].Ann Surg Oncol, 2009, 16:3000-3009.
|
14 |
McGhan LJ, Wasif N, Gray RJ, et al.Use of preoperative magnetic resonance imaging for invasive lobular cancer:good, better, but maybe not the best?[J].Ann Surg Oncol, 2010, 17(suppl 3):255-262.
|
15 |
Nichols HB, Berrington de González A, Lacey JV Jr, et al.Declining incidence of contralateral breast cancer in the United States from 1975 to 2006[J].J Clin Oncol, 2011, 29(12):1564-1569.
|
16 |
Kim J H, Ko E S, Lim Y, et al.Breast Cancer Heterogeneity:MR Imaging Texture Analysis and Survival Outcomes[J].Radiology, 2017.282(3):665-675.
|
17 |
Shao M, Zi J, Wen G, et al.2-fluoro-2-deoxy-D-glucose positron emission tomography versus conventional imaging for the diagnosis of breast cancer and lymph node metastases[J].J Cancer Res Ther, 2018, 14(suppl):S661-S666.
|
18 |
Emaus M J, FBakker M, Peeters P H, et al.MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts:The DENSE Trial Study Design[J].Radiology, 2015, 277(2):527-537.
|
19 |
McCray DK, Grobmyer SR, Pederson HJ.Impact of value based breast cancer care pathway implementation on pre-operative breast magnetic resonance imaging utilization[J].Gland Surg, 2017, 6(1):57-63.
|
20 |
彭卫军,蒋朝霞,刘佩芳.客观认识乳腺癌术前MRI的诊断价值——COMICE研究结果解读[J].磁共振成像,2010,1(3):164-168.
|
21 |
Duygulu G, Oktay A, Bilgen IG, et al.The role of breast MRI in planning the surgical treatment of breast cancer[J].Diagn Interv Radiol, 2012, 18(5):460-467.
|